Attached files

file filename
EX-10.50 - LOAN AGREEMENT AND NOTE PAYABLE DATED JANUARY 13, 2017 - Cell MedX Corp.cmxc_ex1050.htm
EX-32.2 - Cell MedX Corp.cmxc_ex322.htm
EX-32.1 - CERTIFICATION - Cell MedX Corp.cmxc_ex321.htm
EX-31.2 - CERTIFICATION - Cell MedX Corp.cmxc_ex312.htm
EX-31.1 - CERTIFICATION - Cell MedX Corp.cmxc_ex311.htm
EX-21.1 - LIST OF SUBSIDIARIES - Cell MedX Corp.cmxc_ex211.htm
EX-10.54 - LOAN AGREEMENT AND NOTE PAYABLE DATED MAY 5, 2017 - Cell MedX Corp.cmxc_ex1054.htm
EX-10.53 - LOAN AGREEMENT AND NOTE PAYABLE DATED APRIL 18, 2017 - Cell MedX Corp.cmxc_ex1053.htm
EX-10.51 - LOAN AGREEMENT AND NOTE PAYABLE DATED FEBRUARY 14, 2017 - Cell MedX Corp.cmxc_ex1051.htm
EX-10.49 - LOAN AGREEMENT AND NOTE PAYABLE DATED JANUARY 11, 2017 - Cell MedX Corp.cmxc_ex1049.htm
10-K - ANNUAL REPORT - Cell MedX Corp.cmxc_10k.htm

EXHIBIT 10.52




LOAN AGREEMENT

March 8, 2017


Tradex Capital Corp. (the “Lender”) of 1177 W. Hastings Street, Suite 1920, Vancouver, BC V6E 2K3, advanced CAD$30,000 (the “Principal Sum”) to Cell MedX Corp. (the “Borrower”) of 123 W. Nye Ln, Suite 446, Carson City, NV 89706.  The Lender advanced the funds on March 8, 2017.


The Borrower agrees to repay the Principal Sum on demand, together with interest calculated and compounded monthly at the rate of 6% per year (the “Interest”) from March 8, 2017.  The Borrower is liable for repayment for the Principal Sum and accrued Interest and any costs that the Lender incurs in trying to collect the Principal Sum and the Interest.


The Borrower will evidence the debt and its repayment of the Principal Sum and the Interest with a promissory note in the attached form.


LENDER

 

BORROWER

Tradex Capital Corp.

 

Cell MedX Corp.

 

 

 

Per:

 

Per:

 

 

 

 

 

 

/s/ William Friesen

 

/s/ Yanika Silina

William Friesen

 

Yanika Silina, CFO


























PROMISSORY NOTE


Principal Amount: CAD$30,000

March 8, 2017



FOR VALUE RECEIVED Cell MedX Corp., (the “Borrower”) promises to pay on demand to the order of Tradex Capital Corp. (the “Lender”) the sum of $30,000 lawful money of Canada (the “Principal Sum”) together with interest on the Principal Sum from March 8, 2017 (“Effective Date”) both before and after maturity, default and judgment at the Interest Rate as defined below.


For the purposes of this promissory note, Interest Rate means 6 per cent per year.  Interest at the Interest Rate must be calculated and compounded monthly not in advance from and including the Effective Date (for an effective rate of 6.2% per annum calculated monthly), and is payable together with the Principal Sum when the Principal Sum is repaid.


The Borrower may repay the Principal Sum and the Interest in whole or in part at any time.


The Borrower waives presentment, protest, notice of protest and notice of dishonour of this promissory note.


BORROWER

Cell MedX Corp.


Per:



/s/ Yanika Silina

Yanika Silina, CFO